Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents GUERRILLA RF (GUER): RF Semiconductors for Industries & Commerce

Host Jonathan Miller interviews VP Investor Relations: Sam Funchess. He shares some information about Guerrilla RF doing a reverse split to uplift the company into NASDAQ.

semiconductors
June 30, 2023

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: Ideal Power (IPWR) – Power Semiconductors November 25, 2024
Sequire Spotlight Presents: Spectra7 (SPVNF) – Semiconductors Enabling Higher Performance November 20, 2024
Sequire Spotlight Presents ICZOOM Group Inc. (IZM): Connecting Businesses for Seamless Growth October 28, 2023
Sequire Spotlight Presents SmartKem, Inc. (SMTK): Pioneer In Design, Synthesis & Supply Of High-Performance Semiconductor & OTFT Technology February 08, 2023
Sequire Spotlight Presents Aehr Test Systems (AEHR): Building Semiconductor Test Systems November 09, 2022
Sequire Spotlight Presents Guerrilla RF (GUER): A Radio Frequency Semi-Conductor Company November 08, 2022
Sequire Spotlight Presents Guerrilla RF (GUER): Making Waves with Radio Frequency Semiconductors September 19, 2022
Sequire Spotlight Presents SmartKem, Inc. (SMTK): A New Class of Semiconductor Material August 26, 2022
Sequire Spotlight Presents Guerilla RF (GUER): The Experts in Cellular and Wifi Semiconductors June 17, 2022
Sequire Spotlight Presents Cingulate (CING): Single Administration to Optimize Patient Health-Care June 30, 2023

Related Post

Reshaping the World of Electronics

January 18, 2023
Paltalk Adds Game Lobbies for Its Backgammon and Chess Games

January 5, 2023
ToughBuilt Industries, Inc. Announces 1-for-150 Reverse Stock Split as Part of Nasdaq Compliance Plan

April 22, 2022
Todos Medical to Announce Topline Results from Tollovir(TM) Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022

January 12, 2022

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.